[go: up one dir, main page]

DK0488383T3 - 2beta,19-Ethylen-broholdige steroider som aromataseinhibitorer - Google Patents

2beta,19-Ethylen-broholdige steroider som aromataseinhibitorer

Info

Publication number
DK0488383T3
DK0488383T3 DK91120560.7T DK91120560T DK0488383T3 DK 0488383 T3 DK0488383 T3 DK 0488383T3 DK 91120560 T DK91120560 T DK 91120560T DK 0488383 T3 DK0488383 T3 DK 0488383T3
Authority
DK
Denmark
Prior art keywords
aromatase inhibitors
2beta
ethylene bridged
bridged steroids
steroids
Prior art date
Application number
DK91120560.7T
Other languages
Danish (da)
English (en)
Inventor
Norton P Peet
Joseph P Burkhart
Oneal J Johnston
Original Assignee
Merrell Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Pharma Inc filed Critical Merrell Pharma Inc
Application granted granted Critical
Publication of DK0488383T3 publication Critical patent/DK0488383T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J63/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/002—Carbocyclic rings fused
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32—Antioestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Bakery Products And Manufacturing Methods Therefor (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK91120560.7T 1990-11-30 1991-11-29 2beta,19-Ethylen-broholdige steroider som aromataseinhibitorer DK0488383T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/621,184 US5166201A (en) 1990-11-30 1990-11-30 2β,19-ethylene bridged steroids as aromatase inhibitors

Publications (1)

Publication Number Publication Date
DK0488383T3 true DK0488383T3 (da) 1996-09-30

Family

ID=24489093

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91120560.7T DK0488383T3 (da) 1990-11-30 1991-11-29 2beta,19-Ethylen-broholdige steroider som aromataseinhibitorer

Country Status (20)

Country Link
US (1) US5166201A (pt)
EP (1) EP0488383B1 (pt)
JP (1) JP3143876B2 (pt)
KR (1) KR100190776B1 (pt)
CN (1) CN1033975C (pt)
AT (1) ATE142639T1 (pt)
AU (1) AU635444B2 (pt)
CA (1) CA2056638C (pt)
DE (1) DE69122048T2 (pt)
DK (1) DK0488383T3 (pt)
ES (1) ES2094183T3 (pt)
FI (1) FI102073B1 (pt)
GR (1) GR3021981T3 (pt)
HU (1) HU210830B (pt)
IE (1) IE914168A1 (pt)
IL (1) IL100196A (pt)
NO (1) NO180304C (pt)
NZ (1) NZ240738A (pt)
PT (1) PT99661B (pt)
ZA (1) ZA919296B (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19510862A1 (de) * 1995-03-16 1996-09-19 Schering Ag Verwendung von Antiestrogenen zur männlichen Fertilitätskontrolle
WO1999061055A1 (en) 1998-05-22 1999-12-02 The Board Of Trustees Of The Leland Stanford Junior University Bifunctional molecules and therapies based thereon
CN101287411B (zh) 2005-04-28 2013-03-06 普罗秋斯生物医学公司 药物信息系统及其用途
EP1945240B1 (en) 2005-09-16 2016-12-28 Raptor Pharmaceutical Inc Compositions comprising receptor-associated protein (rap) variants specific for cr-containing proteins and uses thereof
DK3395372T3 (da) 2009-02-20 2022-04-19 Enhanx Biopharm Inc System til afgivelse af glutathion-baseret medikament
EP2427178B1 (en) 2009-05-06 2023-01-04 Laboratory Skin Care, Inc. Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3627756A (en) * 1970-04-23 1971-12-14 Searle & Co N-dialkylaminoalkyl-n-(2{62 ,19-epoxy-5{60 -androstan-17{62 -yl)amines/formamides and 3{60 -halo derivatives thereof
US4322416A (en) * 1980-06-27 1982-03-30 Merrell Dow Pharmaceuticals Inc. 10-Alkynyl steroids
GB8501035D0 (en) * 1985-01-16 1985-02-20 Senior J Prostaglandins
US4882322A (en) * 1988-10-27 1989-11-21 Merrell Dow Pharmaceuticals Inc. 3β,17β-hydroxy-substituted steroids and related steroidal compounds

Also Published As

Publication number Publication date
IL100196A0 (en) 1992-08-18
JPH04290898A (ja) 1992-10-15
US5166201A (en) 1992-11-24
CN1061974A (zh) 1992-06-17
CA2056638C (en) 2002-03-05
AU8812891A (en) 1992-06-04
JP3143876B2 (ja) 2001-03-07
HU210830B (en) 1995-08-28
DE69122048D1 (de) 1996-10-17
PT99661B (pt) 1999-05-31
KR100190776B1 (ko) 1999-06-01
NO914710L (no) 1992-06-01
FI915623L (fi) 1992-05-31
ZA919296B (en) 1992-08-26
FI102073B (fi) 1998-10-15
KR920009842A (ko) 1992-06-25
NO914710D0 (no) 1991-11-29
FI915623A0 (fi) 1991-11-28
EP0488383A1 (en) 1992-06-03
HU913739D0 (en) 1992-02-28
HUT59937A (en) 1992-07-28
EP0488383B1 (en) 1996-09-11
PT99661A (pt) 1992-10-30
ATE142639T1 (de) 1996-09-15
DE69122048T2 (de) 1997-02-20
ES2094183T3 (es) 1997-01-16
GR3021981T3 (en) 1997-03-31
FI102073B1 (fi) 1998-10-15
NO180304B (no) 1996-12-16
NZ240738A (en) 1993-11-25
IE914168A1 (en) 1992-06-03
AU635444B2 (en) 1993-03-18
IL100196A (en) 1996-03-31
CA2056638A1 (en) 1992-05-31
CN1033975C (zh) 1997-02-05
NO180304C (no) 1997-04-02

Similar Documents

Publication Publication Date Title
IT1283588B1 (it) Miscela sinergica di agenti stabilizzanti
DK1040108T3 (da) Orthoanthranilamidderivater som antikoagulanter
BR0000654A (pt) Preparação de composição de borracha vulcanizada com peróxido e artigos tendo ela pelo menos como um dos seus componentes
DK0488383T3 (da) 2beta,19-Ethylen-broholdige steroider som aromataseinhibitorer
DK0988312T3 (da) 17beta-allyloxy(thio)alkyl-androstanderivater til modulering af meiose
DK0563813T3 (da) Transdermale præparater
ES2077867T3 (es) 3-carbamoil-4-hidroxicumarinas antihelminticas y anticoccidiales, procedimiento de uso y composiciones.
BG103271A (en) Derivatives of n-(benzothiazol-2-yl) piperidine-1-ethaneamines, method for their preparation and application as therapeutical means
DK0559706T3 (da) 2 beta,19-methylenamino-broforbundne steroider som aromataseinhibitorer.
FI853768L (fi) Synergistisk sammansaettning som foerhindrar befruktning.
ES2100315T3 (es) Nuevos esteroides 16-metilo sustituidos derivados de la pregna-1,4-dieno-3,20-diona, su preparacion, su aplicacion a la preparacion de esteroides 16-metileno y nuevos productos intermedios.
MXPA03000845A (es) Estrogenos substituidos por 16alfa-metilo o etilo.
NO911236L (no) Fremgangsmaate for fremstilling av haloethyl-substituerte steroidale enzyminhibitorer.
CA2032311A1 (en) 2,19-methyleneoxy and 2,19-methylenethio bridged steroids as aromatase and 19-hydroxylase inhibitors
JPS52131580A (en) N-substituted pyridinium-2-sulfonylimines, containing same as active ingredient
NO20053117L (no) Cyklopenta[c]isoksazol-3-aminer anvendt som materialbeskyttelsesmidler..
NO20020194L (no) Aminmodifiserte pseudomycin forbindelser
DK14083A (da) Analogifremgangsmaade til fremstilling af derivater af 4-desacetyl-vincaleucoblastin-c-3-carboxhydrazid
ECSP951417A (es) Nuevos derivados de la eritromicina, su procedimiento de preparacion y su aplicación como medicamentos